5315-24-2

Basic information

• Product Name: 2-METHYL-6-HYDRAZINOPYRIDINE
• Synonyms: 2-METHYL-6-HYDRAZINOPYRIDINE;2-Hydrazinyl-6-methylpyridine;2-hydrazino-6-methylpyridine(SALTDATA: 1.3HCl 0.7H2O);Pyridine, 2-hydrazinyl-6-methyl-;2-Hydrazinyl-6-Methylpyridine(WXC01942)
• CAS NO: 5315-24-2
• Molecular Formula: C₆H₉N₃
• Molecular Weight: 123.16
• Product Categories: Heterocycle-Pyridine series;amine
• Mol File: 5315-24-2.mol
• Article Data: 13

Chemical Properties

• Melting Point: 54-56 °C
• Boiling Point: 262.196°C at 760 mmHg
• Flash Point: 112.372°C
• Appearance: /
• Density: 1.167g/cm³
• Vapor Pressure: 0.011mmHg at 25°C
• Refractive Index: 1.633
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• PKA: 9.73±0.70(Predicted)
• CAS DataBase Reference: 2-METHYL-6-HYDRAZINOPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-METHYL-6-HYDRAZINOPYRIDINE(5315-24-2)
• EPA Substance Registry System: 2-METHYL-6-HYDRAZINOPYRIDINE(5315-24-2)

Safety Data

• Hazardous Substances Data: 5315-24-2(Hazardous Substances Data)

Usage

General Description

2-Methyl-6-hydrazinopyridine, also known as Lepephyrin or LEP, is a chemical compound with the molecular formula C6H8N4. It is a hydrazine derivative that is used in the synthesis of pharmaceuticals and agrochemicals. 2-Methyl-6-hydrazinopyridine has been studied for its potential use as a corrosion inhibitor and as a precursor to a range of heterocyclic compounds. It is also known for its ability to complex with metal ions, making it useful in coordination chemistry. Additionally, this compound has been researched for its anti-tumor and anti-cancer properties, demonstrating its potential as a valuable tool in medicinal chemistry.

InChI:InChI=1/C6H9N3/c1-5-3-2-4-6(8-5)9-7/h2-4H,7H2,1H3,(H,8,9)

Upstream product

• 5315-25-3 2-bromo-6-methylpyridine 
• 407-22-7 2-fluoro-6-methylpyridine 
• 18368-63-3 6-chloro-2-picoline 
• 38557-71-0 2-chloro-6-methylpyrazine 

Downstream Products

• 701979-19-3 4-[1-(6-methyl-pyridin-2-yl)-5-quinoxalin-6-yl-1H-[1,2,4]triazol-3-yl]-benzonitrile 
• 957655-81-1 C₂₃H₁₈N₄O₂ 
• 1431142-72-1 C₂₇H₂₄Cl₂F₃N₇O₂ 
• 1427301-11-8 C₂₂H₁₆Cl₂F₃N₇ 
• 723286-86-0 3-(trifluoromethyl)-5-methyl-[1,2,4]triazolo[4,3-a]pyrazine 
• 4926-18-5 5-methyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one 
• 4926-14-1 5-methyl-3-phenyl-[1,2,4]triazolo[4,3-a]pyridine 
• 96206-92-7 2-methyl-6-(phenylethynyl)pyridine 
• 5528-51-8 5-methyl-[1,2,4]triazolo[4,3-a]pyridine 

Relevant articles and documents

TRICYCLIC PSYCHOPLASTOGENS AND USES THEREOF

Disclosed herein are compounds, compositions, and methods for promoting neuronal growth and/or improving neuronal structure with the compounds and compositions disclosed herein. Also described are methods of treating diseases or disorders that are mediated by the loss of synaptic connectivity and/or plasticity, such as neurological diseases and disorders, with non-hallucinogenic psychoplastogens.

Pyrazolo-cyclic compound, pharmaceutical composition containing pyrazolo-cyclic compound, and preparation method and application of pyrazolo-cyclic compound

The invention belongs to the field of medicinal chemistry, and relates to a pyrazolo-cyclic compound, a pharmaceutical composition containing the pyrazolo-cyclic compound, and a preparation method and application of the pyrazolo-cyclic compound. Specifica

ASK1 inhibitor and application thereof

The invention relates to compounds represented by a general formula (I) shown in the specification, a pharmaceutically acceptable salt and ester, or a stereoisomer of the compounds. The invention alsorelates to a preparation method of the compounds, a pharmaceutical preparation and a pharmaceutical composition containing the compounds. The compounds provided by the invention can effectively inhibit the amino acid phosphorylation of ASK1 and inhibit the activation of the ASK1; therefore, the compounds can treat and/or prevent ASK1-mediated diseases and related diseases.